Login

Unlocking Your HSA's Potential for Retirement | David Seufer, CFA of Gravitas Wealth Planning 00:10:00

Share On Facebook Share On Twitter

David Seufer is the CFA of Gravitas Wealth Planning

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Actinogen CEO Steve Goulet Discusses Promising Alzheimer's Treatment and Company Growth|Dr Steven Gourlay,CEO,Actinogen Medical
00:10:00
Jonathan Thomas and Primerica Strategic Partner, American Century | Jonathan Thomas, CEO , American Century Investments.
00:10:00
"Brinova: Transforming Communities with Affordable Housing in Southern Sweden"|CEO,Brinova Fastigheter AB (publ)
00:10:00
Senior Resources: High-Grade Gold Opportunities in British Columbia's Golden Triangle
00:10:00
Building Trust: The Key to Successful Client Relationships
00:10:00
OrbiMed is considered to be one of the largest dedicated healthcare investment firms in the world|Trevor, Portfolio Manager,OrbiMed Advisors
00:10:00
Building High-Performing Teams Through Respect, Integrity, and Continuous Development at Tokyo Marine
00:10:00
Machine Learning Revolutionizing Pricing in the Corporate Bond Market
00:10:00
Pro Vyx: Enhancing Safety and Productivity with Customized Camera Systems
00:10:00
Balancing Growth and Capital Preservation: Mark Burgess on the Bennelong Kardinia Absolute Return Fund | Mark Burgess - Portfolio Manager, Kardinia Capital
00:10:00
Bridging the Gap with Small-Mid Value | William Blair Investment Management
00:10:00
Indian Equity Markets: Resilience and Strategic Outlook | Nimesh Shah, CEO , ICICI Prudential Mutual Fund .

© 2026 Nehu